Back to all research

Melanotan II: What the Research Says

July 7, 2026

Melanotan II is widely discussed online, but the published science — and the safety literature in particular — deserves careful reading. This overview summarizes what research reports, strictly within a laboratory-research context.

What Is Melanotan II?

Melanotan II (MT-II) is a synthetic cyclic heptapeptide (Ac-Nle-c[Asp-His-DPhe-Arg-Trp-Lys]-NH2) modeled on the 4–10 melanocortin-receptor binding region shared by α-MSH and ACTH, stabilized by a lactam bridge. It is described in the literature as a non-selective agonist of melanocortin receptors (MC1R, MC3R, MC4R, MC5R).

Mechanisms Studied in Research

  • Melanogenesis. By activating MC1R on melanocytes, MT-II has been studied for its association with eumelanin production and pigmentation independent of UV exposure.
  • Central melanocortin activity. As a broad melanocortin agonist, it has been examined in research relating to appetite and other MC4R-mediated processes.

The State of the Evidence — and Safety Caveats

  • Unregulated status. The literature explicitly describes Melanotan II as an unlicensed, unregulated synthetic peptide. It is not FDA-approved.
  • Documented safety concerns. Published case reports have associated MT-II use with adverse effects. Independent of any research interest, this safety profile is an essential part of the record.

Key Takeaways

  • Melanotan II is a synthetic non-selective melanocortin-receptor agonist studied in relation to melanogenesis.
  • It is unregulated and not FDA-approved, and the literature documents safety concerns.
  • Research-grade material is for laboratory research use only.

References

  • “Melanotan.” ScienceDirect (S1578219012001382).
  • “Changes in Oral Mucosa Associated with Melanotan II Injections: A Case Report.” Life, 2026;16(2):265.
  • “Melanocortin peptide therapeutics: Historical milestones, clinical studies and commercialization.” ScienceDirect.

Research Use, Legal Status & Handling

Material supplied for research is intended for in-vitro laboratory research use only. It is not a dietary supplement, drug, cosmetic, or food. Where an approved pharmaceutical version of a compound exists, research-grade material is not that approved product and is not intended for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition. Researchers are solely responsible for compliance with all applicable federal, state, and local laws and regulations in their jurisdiction. Research peptides are generally stored lyophilized, protected from light and heat, with reconstitution and handling performed per standard laboratory protocols.

Disclaimer: This article is provided for educational and informational purposes only and summarizes published laboratory and, where noted, clinical research. It is not medical advice or a recommendation for any form of use. Research-grade material is intended strictly for in-vitro research use only — not for human or veterinary consumption. Always consult a qualified professional regarding health-related questions.